论文部分内容阅读
神经系统免疫性疾病是一组常见病,其发病机制尚未彻底阐明,治疗结果亦不一致。研究这类疾病的脑脊液细胞学(Cerebrospinal fluid cytology,CSFC)对阐明发病机制、判断临床疗效及预后有一定价值。我们对90例神经系统免疫性疾病住院患者的CSFC结果进行了对比分析,报告如下。 1 临床资料 1.1 对象 全组男42例,女48例;年龄3～70岁;平均29.0岁。共分三组:A组为非特异性脑或(和)脊髓炎,计38例(脱髓鞘脑炎25例,播散性脑或脑脊髓炎8例,急性非特异性脊髓炎5例);B组为多发性硬化(Ms),计22例(Devic氏病8例、一般Ms 24例);C组为格林-巴利综合征(GBS)20例。
Neurological immune diseases are a group of common diseases, the pathogenesis has not been fully elucidated, the treatment results are inconsistent. Cerebrospinal fluid cytology (CSF) for studying these diseases is of value in elucidating the pathogenesis, judging the clinical efficacy and prognosis. We conducted a comparative analysis of 90 CSCs from hospitalized patients with neurological immune diseases and reported the following. 1 Clinical data 1.1 The whole group of 42 men and 48 women, aged 3 to 70 years, mean 29.0 years. A total of 38 patients (demyelination encephalitis 25, disseminated brain or encephalomyelitis 8, acute nonspecific myelitis 5); group A was nonspecific brain or (and) myelitis 38 cases; B group was multiple sclerosis (Ms), 22 cases (Devic’s disease in 8 cases, 24 cases in general Ms); C group was 20 cases of Guillain-Barre syndrome (GBS).